샘플 요청 목록

 카트 문의
시장보고서
상품코드
1941511

유착 방지제 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 형상별, 용도별, 지역별, 부문별 예측(2026-2033년)

Adhesion Barrier Market Size, Share & Trends Analysis Report By Product (Synthetic, Natural), By Formulation (Film/Mesh, Gel), By Application (Cardiovascular, Neurological Surgery), By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유착 방지제 시장 요약

세계의 유착 방지제 시장 규모는 2025년에 10억 5,000만 달러로 평가되었으며, 2033년까지 19억 달러에 달할 것으로 예측됩니다.

2026년부터 2033년까지 CAGR 7.8%로 성장할 것으로 예상됩니다. 시장의 주요 촉진요인은 고령 인구의 증가와 수술 건수의 증가입니다.

수술 후 합병증 위험이 높은 침습적 수술의 빈도가 급증하면서 시장 성장을 견인할 것으로 예상됩니다. 그러나 수술 후 유착 위험의 증가에도 불구하고 접근성 문제, 건강 교육 부족, 치료의 중요성에 대한 인식 부족 등의 장벽이 여전히 존재합니다.

유착 방지제 산업은 몇 가지 주요 요인으로 인해 큰 성장이 예상됩니다. 의료 인프라의 개선과 외상 치료 센터의 증가가 시장을 주도할 것입니다. 또한, 스포츠 관련 부상 발생률 증가도 시장 성장에 기여할 것으로 예상됩니다. 스탠포드 소아 의료 센터의 최신 데이터에 따르면, 스포츠에 참여하는 약 3,000만 명의 어린이 중 매년 10% 이상이 부상을 당하고 있습니다.

고령화 사회가 진행됨에 따라 다양한 질병과 외상을 앓고 있는 노인이 증가함에 따라 예측 기간 동안 유착 방지제의 세계 사용량은 크게 증가할 것으로 예상됩니다. 세계보건기구(WHO)의 추산에 따르면, 전 세계 노인 인구는 2014년 8억 4,100만 명에서 2050년에는 20억 명 이상으로 증가할 것으로 예측됩니다. 노인은 COPD(만성폐쇄성폐질환), 수면무호흡증 등 호흡기질환에 걸리기 쉬운 경향이 있습니다. 예를 들어, 세계보건기구(WHO)에 따르면 호흡기질환의 유병률은 전 세계적으로 약 7.6%로 보고되고 있습니다. 따라서 고령 인구의 증가는 제조업체의 환자층 확대로 이어져 시장 성장을 촉진할 것으로 예상됩니다.

의료비 지출 증가와 더불어 다양한 유착 방지제의 FDA 승인 증가 등 여러 요인으로 인해 업계가 성장하고 있습니다. 2023년 2월, 어드밴스드 메디컬 솔루션즈(AMS)는 조직 접착제 전문 기업 커넥시콘 메디컬을 약 750만 달러에 인수했습니다. 이번 인수는 커넥시콘의 기술과 전문성을 AMS의 세계 R&D 및 상업적 활동에 통합함으로써 AMS의 외과적 상처 관리 및 유착 방지제 포트폴리오를 강화하고 혁신적인 조직 치유 솔루션 분야에서 리더십을 강화한다는 AMS의 전략적 목표를 강화하는 것을 목표로 합니다.

암, 신경질환, 부인과 질환, 안과 질환, 치과 질환 등의 질병 유병률은 해마다 증가하고 있습니다. 이러한 질환을 치료하기 위해서는 때로는 외과 수술이나 미세 수술이 필요하기 때문에 유착 방지제에 대한 수요가 증가하고 있습니다. 예를 들어, 세계보건기구(WHO)가 발표한 통계에 따르면, 암 발병률은 증가 추세에 있습니다. 연간 약 820만 명이 암으로 사망하고 있으며, 이는 전 세계 사망자 수의 13.0%를 차지합니다. 또한, 향후 수십 년 동안 신규 암 환자 수는 70.0% 증가할 것으로 예상되며, 100가지 이상의 암이 존재하고 각기 다른 치료법이 필요한 암이 존재합니다.

자주 묻는 질문

  • 유착 방지제 시장 규모는 어떻게 예측되나요?
  • 유착 방지제 시장의 주요 성장 요인은 무엇인가요?
  • 고령화 사회가 유착 방지제 시장에 미치는 영향은 무엇인가요?
  • 유착 방지제 산업의 성장에 기여하는 요인은 무엇인가요?
  • 유착 방지제 시장에서 주요 기업은 어디인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 유착 방지제 시장 변수, 동향 및 범위

제4장 유착 방지제 시장 : 제품별 추정·동향 분석

제5장 유착 방지제 시장 : 형상별 추정·동향 분석

제6장 유착 방지제 시장 : 용도별 추정·동향 분석

제7장 유착 방지제 시장 : 지역별 추정·동향 분석

제8장 경쟁 구도

KSM 26.03.13

Adhesion Barrier Market Summary

The global adhesion barrier market size was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.90 billion by 2033, growing at a CAGR of 7.8% from 2026 to 2033. The key drivers of the market are the rising geriatric population, coupled with the increasing number of surgical procedures.

The surging frequency of invasive surgeries with a high risk of postoperative complications is anticipated to trigger market growth. However, with the rising risk of post-operation adhesion, the market is still witnessing barriers in terms of accessibility, lack of health education, and lack of awareness about the importance of treatment.

The adhesion barrier industry is expected to witness significant growth due to a few key factors. The improvement in healthcare infrastructure and the increasing availability of trauma care centers will drive the market forward. Additionally, the growing incidence of sports-related injuries is also expected to contribute to the growth of the market. Recent data from Stanford Children's Health shows that out of the approximately 30 million children who participate in some form of sports, over 10% experience injuries each year.

The global usage of adhesion barriers is anticipated to increase substantially over the forecast period, owing to the rising geriatric population, as they suffer from various diseases and injuries. According to estimates published by the WHO, the global elderly population is expected to increase from 841 million in 2014 to more than 2 billion in 2050. Elderly people are susceptible to respiratory diseases such as COPD and sleep apnea. For instance, according to the WHO, the prevalence of respiratory diseases is about 7.6% worldwide. Therefore, the growing geriatric population is expected to expand the patient pool for manufacturers and propel market growth.

The industry is witnessing growth due to several factors. Rising healthcare expenditure, along with increased FDA approval for various adhesion barrier products, is contributing to the market's expansion. In February 2023, Advanced Medical Solutions (AMS) acquired tissue adhesive specialist Connexicon Medical for around USD 7.5 million. The acquisition aims to strengthen AMS's surgical wound care and adhesion barrier portfolio by integrating Connexicon's technology and expertise into its global R&D and commercial operations, reinforcing AMS's strategic objective of advancing leadership in innovative tissue-healing solutions.

The prevalence of diseases such as cancer, neurological disorders, gynecological disorders, ophthalmic disorders, and dental disorders is increasing year-on-year. The treatment of these disorders requires surgical procedures and microsurgery at certain times, increasing the demand for adhesion barriers. For instance, the prevalence of cancer is rising, as per the statistics published by the World Health Organization (WHO). Approximately 8.2 million die each year from cancer, which accounts for 13.0% deaths worldwide. Moreover, it is anticipated that there will be a 70.0% increase in the new cases of cancer over the next couple of decades, and over 100 types of cancer exist, which require unique therapy.

Global Adhesion Barrier Market Report Segmentation

This report forecasts revenue growth at global, regional, & country levels as well as provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global adhesion barrier market report on the basis of product, formulation, application, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Synthetic Adhesion Barriers
    • Hyaluronic acid
    • Regenerated cellulose
    • Polyethylene glycol
    • Others
  • Natural Adhesion Barriers
    • Collagen & Protein
    • Fibrin
  • Formulation Outlook (Revenue, USD Million, 2021 - 2033)
  • Film/Mesh
  • Gel
  • Liquid
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Gynecological Surgeries
    • Synthetic Adhesion Barriers
    • Natural Adhesion Barriers
  • Abdominal General Surgeries
    • Synthetic Adhesion Barriers
    • Natural Adhesion Barriers
  • Orthopedic Surgeries
    • Synthetic Adhesion Barriers
    • Natural Adhesion Barriers
  • Cardiovascular Surgeries
    • Synthetic Adhesion Barriers
    • Natural Adhesion Barriers
  • Neurological Surgeries
    • Synthetic Adhesion Barriers
    • Natural Adhesion Barriers
  • Urological Surgeries
    • Synthetic Adhesion Barriers
    • Natural Adhesion Barriers
  • Others
    • Synthetic Adhesion Barriers
    • Natural Adhesion Barriers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Switzerland
    • Russia
    • Poland
    • Netherland
    • Greece
    • Norway
    • Sweden
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Vietnam
    • New Zealand
    • Malaysia
    • Hong Kong
    • Thailand
    • Singapore
    • Taiwan
  • Latin America
    • Brazil
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Oman
    • Egypt
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. By product
      • 1.1.1.1. Synthetic Adhesion Barriers
        • 1.1.1.1.1. Hyaluronic acid
        • 1.1.1.1.2. Regenerated cellulose
        • 1.1.1.1.3. Polyethylene glycol
        • 1.1.1.1.4. Others
      • 1.1.1.2. Natural Adhesion Barriers
        • 1.1.1.2.1. Collagen & Protein
        • 1.1.1.2.2. Fibrin
    • 1.1.2. By formulation
      • 1.1.2.1. Film/Mesh
      • 1.1.2.2. Gel
      • 1.1.2.3. Liquid
    • 1.1.3. By application
      • 1.1.3.1. Gynecological surgeries
        • 1.1.3.1.1. Synthetic adhesion barrier
        • 1.1.3.1.2. Natural adhesion barrier
      • 1.1.3.2. Abdominal general surgeries
        • 1.1.3.2.1. Synthetic adhesion barrier
        • 1.1.3.2.2. Natural adhesion barrier
      • 1.1.3.3. Orthopedic surgeries
        • 1.1.3.3.1. Synthetic adhesion barrier
        • 1.1.3.3.2. Natural adhesion barrier
      • 1.1.3.4. Cardiovascular surgeries
        • 1.1.3.4.1. Synthetic adhesion barrier
        • 1.1.3.4.2. Natural adhesion barrier
      • 1.1.3.5. Neurological surgeries
        • 1.1.3.5.1. Synthetic adhesion barrier
        • 1.1.3.5.2. Natural adhesion barrier
      • 1.1.3.6. Urological surgeries
        • 1.1.3.6.1. Synthetic adhesion barrier
        • 1.1.3.6.2. Natural adhesion barrier
      • 1.1.3.7. Others
        • 1.1.3.7.1. Synthetic adhesion barrier
        • 1.1.3.7.2. Natural adhesion barrier
    • 1.1.4. Region Scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Formulation outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Adhesion Barrier Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Rising geriatric population
      • 3.4.1.2. Increasing number of sports related injury
      • 3.4.1.3. Increasing prevalence of chronic disease
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Reluctance towards the usage of adhesion barrier among surgeons
      • 3.4.2.2. Low awareness about post-surgical complication
    • 3.4.3. Industry challenges
  • 3.5. Adhesion Barrier Market Analysis Tools
    • 3.5.1. Industry analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major deals & strategic alliances analysis
    • 3.5.4. Market entry strategies

Chapter 4. Adhesion Barrier Market by Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Adhesion Barrier Market by Component Outlook
    • 4.3.1. Synthetic adhesion barrier
      • 4.3.1.1. Synthetic adhesion market estimates and forecast, 2021 - 2033 (USD million)
      • 4.3.1.2. Hyaluronic acid
        • 4.3.1.2.1. Hyaluronic acid market estimates and forecast, 2021 - 2033 (USD million)
      • 4.3.1.3. Regenerated cellulose
        • 4.3.1.3.1. Regenerated cellulose acid market estimates and forecast, 2021 - 2033 (USD million)
      • 4.3.1.4. Polyethylene glycol
        • 4.3.1.4.1. Polyethylene glycol market estimates and forecast, 2021 - 2033 (USD million)
      • 4.3.1.5. Others
        • 4.3.1.5.1. Others glycol market estimates and forecast, 2021 - 2033 (USD million)
    • 4.3.2. Natural adhesion barrier
      • 4.3.2.1. Natural adhesion market estimates and forecast, 2021 - 2033 (USD million)
      • 4.3.2.2. Collagen & protein
        • 4.3.2.2.1. Collagen & Protein market estimates and forecast, 2021 - 2033 (USD million)
      • 4.3.2.3. Fibrin
        • 4.3.2.3.1. Fibrin market estimates and forecast, 2021 - 2033 (USD million)

Chapter 5. Adhesion Barrier Market: By Formulation Estimates & Trend Analysis

  • 5.1. Formulation Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Adhesion Barrier Market by Formulation Outlook
    • 5.3.1. Film/Mesh
      • 5.3.1.1. Film/Mesh market estimates and forecast, 2021 - 2033 (USD million)
    • 5.3.2. Gel
      • 5.3.2.1. Gel market estimates and forecast, 2021 - 2033 (USD million)
    • 5.3.3. Liquid
      • 5.3.3.1. Liquid market estimates and forecast, 2021 - 2033 (USD million)

Chapter 6. Adhesion Barrier Market: By Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Adhesion Barrier Market by Application Outlook
    • 6.3.1. Gynecological surgeries
      • 6.3.1.1. Gynecological surgeries market estimates and forecast, 2021 - 2033 (USD million)
      • 6.3.1.2. Gynecological surgeries market estimates and forecast, by application 2021 - 2033 (USD million)
        • 6.3.1.2.1. Synthetic adhesion barrier
        • 6.3.1.2.2. Natural adhesion barrier
      • 6.3.1.3. Abdominal general surgeries market estimates and forecast, 2021 - 2033 (USD million)
      • 6.3.1.4. Abdominal general surgeries market estimates and forecast, by application 2021 - 2033 (USD million)
        • 6.3.1.4.1. Synthetic adhesion barrier
        • 6.3.1.4.2. Natural adhesion barrier
      • 6.3.1.5. Orthopedic surgeries market estimates and forecast, 2021 - 2033 (USD million)
      • 6.3.1.6. Orthopedic general surgeries market estimates and forecast, by application 2021 - 2033 (USD million)
        • 6.3.1.6.1. Synthetic adhesion barrier
        • 6.3.1.6.2. Natural adhesion barrier
      • 6.3.1.7. Cardiovascular surgeries market estimates and forecast, 2021 - 2033 (USD million)
      • 6.3.1.8. Cardiovascular general surgeries market estimates and forecast, by application 2021 - 2033 (USD million)
        • 6.3.1.8.1. Synthetic adhesion barrier
        • 6.3.1.8.2. Natural adhesion barrier
      • 6.3.1.9. Neurological surgeries market estimates and forecast, 2021 - 2033 (USD million)
      • 6.3.1.10. Neurological surgeries market estimates and forecast, by application 2021 - 2033 (USD million)
        • 6.3.1.10.1. Synthetic adhesion barrier
        • 6.3.1.10.2. Natural adhesion barrier
      • 6.3.1.11. Urological surgeries market estimates and forecast, 2021 - 2033 (USD million)
      • 6.3.1.12. Urological surgeries market estimates and forecast, by application 2021 - 2033 (USD million)
        • 6.3.1.12.1. Synthetic adhesion barrier
        • 6.3.1.12.2. Natural adhesion barrier
      • 6.3.1.13. Other surgeries market estimates and forecast, 2021 - 2033 (USD million)
      • 6.3.1.14. Other surgeries market estimates and forecast, by application 2021 - 2033 (USD million)
        • 6.3.1.14.1. Synthetic adhesion barrier
        • 6.3.1.14.2. Natural adhesion barrier

Chapter 7. Adhesion Barrier Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2025
    • 7.4.1. North America
    • 7.4.2. Europe
    • 7.4.3. Asia Pacific
    • 7.4.4. Latin America
    • 7.4.5. Middle East and Africa
  • 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.5.1. North America
    • 7.5.2. Europe
    • 7.5.3. Asia Pacific
    • 7.5.4. Latin America
    • 7.5.5. Middle East and Africa
  • 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2033:
  • 7.7. North America
    • 7.7.1. Market estimates and forecast, 2021 - 2033 (USD million)
    • 7.7.2. U.S.
      • 7.7.2.1. U.S. Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.7.2.2. Key Country Dynamics
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. Competitive Scenario
    • 7.7.3. Canada
      • 7.7.3.1. Canada Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.7.3.2. Key Country Dynamics
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Competitive Scenario
    • 7.7.4. Mexico
      • 7.7.4.1. Mexico Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.7.4.2. Key Country Dynamics
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. Competitive Scenario
  • 7.8. Europe
    • 7.8.1. Market estimates and forecast, 2021 - 2033 (USD million)
    • 7.8.2. UK
      • 7.8.2.1. UK Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.2.2. Key Country Dynamics
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement Scenario
      • 7.8.2.5. Competitive Scenario
    • 7.8.3. Germany
      • 7.8.3.1. Germany Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.3.2. Key Country Dynamics
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement Scenario
      • 7.8.3.5. Competitive Scenario
    • 7.8.4. France
      • 7.8.4.1. France Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.4.2. Key Country Dynamics
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement Scenario
      • 7.8.4.5. Competitive Scenario
    • 7.8.5. Italy
      • 7.8.5.1. Italy Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.5.2. Key Country Dynamics
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement Scenario
      • 7.8.5.5. Competitive Scenario
    • 7.8.6. Spain
      • 7.8.6.1. Spain Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.6.2. Key Country Dynamics
      • 7.8.6.3. Regulatory Framework
      • 7.8.6.4. Reimbursement Scenario
      • 7.8.6.5. Competitive Scenario
    • 7.8.7. Switzerland
      • 7.8.7.1. Switzerland Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.7.2. Key Country Dynamics
      • 7.8.7.3. Regulatory Framework
      • 7.8.7.4. Reimbursement Scenario
      • 7.8.7.5. Competitive Scenario
    • 7.8.8. Russia
      • 7.8.8.1. Russia Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.8.2. Key Country Dynamics
      • 7.8.8.3. Regulatory Framework
      • 7.8.8.4. Reimbursement Scenario
      • 7.8.8.5. Competitive Scenario
    • 7.8.9. Poland
      • 7.8.9.1. Poland Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.9.2. Key Country Dynamics
      • 7.8.9.3. Regulatory Framework
      • 7.8.9.4. Reimbursement Scenario
      • 7.8.9.5. Competitive Scenario
    • 7.8.10. Netherlands
      • 7.8.10.1. Netherlands Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.10.2. Key Country Dynamics
      • 7.8.10.3. Regulatory Framework
      • 7.8.10.4. Reimbursement Scenario
      • 7.8.10.5. Competitive Scenario
    • 7.8.11. Greece
      • 7.8.11.1. Greece Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.11.2. Key Country Dynamics
      • 7.8.11.3. Regulatory Framework
      • 7.8.11.4. Reimbursement Scenario
      • 7.8.11.5. Competitive Scenario
    • 7.8.12. Sweden
      • 7.8.12.1. Sweden Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.12.2. Key Country Dynamics
      • 7.8.12.3. Regulatory Framework
      • 7.8.12.4. Reimbursement Scenario
      • 7.8.12.5. Competitive Scenario
    • 7.8.13. Denmark
      • 7.8.13.1. Denmark Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.13.2. Key Country Dynamics
      • 7.8.13.3. Regulatory Framework
      • 7.8.13.4. Reimbursement Scenario
      • 7.8.13.5. Competitive Scenario
    • 7.8.14. Norway
      • 7.8.14.1. Norway Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.8.14.2. Key Country Dynamics
      • 7.8.14.3. Regulatory Framework
      • 7.8.14.4. Reimbursement Scenario
      • 7.8.14.5. Competitive Scenario
  • 7.9. Asia Pacific
    • 7.9.1. Market estimates and forecast, 2021 - 2033 (USD million)
    • 7.9.2. Japan
      • 7.9.2.1. Japan Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.2.2. Key Country Dynamics
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Reimbursement Scenario
      • 7.9.2.5. Competitive Scenario
    • 7.9.3. China
      • 7.9.3.1. China Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.3.2. Key Country Dynamics
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Reimbursement Scenario
      • 7.9.3.5. Competitive Scenario
    • 7.9.4. India
      • 7.9.4.1. India Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.4.2. Key Country Dynamics
      • 7.9.4.3. Regulatory Framework
      • 7.9.4.4. Reimbursement Scenario
      • 7.9.4.5. Competitive Scenario
    • 7.9.5. Australia
      • 7.9.5.1. Australia Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.5.2. Key Country Dynamics
      • 7.9.5.3. Regulatory Framework
      • 7.9.5.4. Reimbursement Scenario
      • 7.9.5.5. Competitive Scenario
    • 7.9.6. South Korea
      • 7.9.6.1. South Korea Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.6.2. Key Country Dynamics
      • 7.9.6.3. Regulatory Framework
      • 7.9.6.4. Reimbursement Scenario
      • 7.9.6.5. Competitive Scenario
    • 7.9.7. Vietnam
      • 7.9.7.1. Vietnam Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.7.2. Key Country Dynamics
      • 7.9.7.3. Regulatory Framework
      • 7.9.7.4. Reimbursement Scenario
      • 7.9.7.5. Competitive Scenario
    • 7.9.8. New Zealand
      • 7.9.8.1. New Zealand Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.8.2. Key Country Dynamics
      • 7.9.8.3. Regulatory Framework
      • 7.9.8.4. Reimbursement Scenario
      • 7.9.8.5. Competitive Scenario
    • 7.9.9. Malaysia
      • 7.9.9.1. Malaysia Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.9.2. Key Country Dynamics
      • 7.9.9.3. Regulatory Framework
      • 7.9.9.4. Reimbursement Scenario
      • 7.9.9.5. Competitive Scenario
    • 7.9.10. Hong Kong
      • 7.9.10.1. Hong Kong Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.10.2. Key Country Dynamics
      • 7.9.10.3. Regulatory Framework
      • 7.9.10.4. Reimbursement Scenario
      • 7.9.10.5. Competitive Scenario
    • 7.9.11. Singapore
      • 7.9.11.1. Singapore Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.11.2. Key Country Dynamics
      • 7.9.11.3. Regulatory Framework
      • 7.9.11.4. Reimbursement Scenario
      • 7.9.11.5. Competitive Scenario
    • 7.9.12. Taiwan
      • 7.9.12.1. Taiwan Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.12.2. Key Country Dynamics
      • 7.9.12.3. Regulatory Framework
      • 7.9.12.4. Reimbursement Scenario
      • 7.9.12.5. Competitive Scenario
    • 7.9.13. Thailand
      • 7.9.13.1. Thailand Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.9.13.2. Key Country Dynamics
      • 7.9.13.3. Regulatory Framework
      • 7.9.13.4. Reimbursement Scenario
      • 7.9.13.5. Competitive Scenario
  • 7.10. Latin America
    • 7.10.1. Market estimates and forecast, 2021 - 2033 (USD million)
    • 7.10.2. Brazil
      • 7.10.2.1. Brazil Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.10.2.2. Key Country Dynamics
      • 7.10.2.3. Regulatory Framework
      • 7.10.2.4. Reimbursement Scenario
      • 7.10.2.5. Competitive Scenario
    • 7.10.3. Colombia
      • 7.10.3.1. Colombia Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.10.3.2. Key Country Dynamics
      • 7.10.3.3. Regulatory Framework
      • 7.10.3.4. Reimbursement Scenario
      • 7.10.3.5. Competitive Scenario
    • 7.10.4. Argentina
      • 7.10.4.1. Argentina Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.10.4.2. Key Country Dynamics
      • 7.10.4.3. Regulatory Framework
      • 7.10.4.4. Reimbursement Scenario
      • 7.10.4.5. Competitive Scenario
    • 7.10.5. Chile
      • 7.10.5.1. Chile Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.10.5.2. Key Country Dynamics
      • 7.10.5.3. Regulatory Framework
      • 7.10.5.4. Reimbursement Scenario
      • 7.10.5.5. Competitive Scenario
  • 7.11. Middle East & Africa
    • 7.11.1. Market estimates and forecast, 2021 - 2033 (USD million)
    • 7.11.2. South Africa
      • 7.11.2.1. South Africa Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.11.2.2. Key Country Dynamics
      • 7.11.2.3. Regulatory Framework
      • 7.11.2.4. Reimbursement Scenario
      • 7.11.2.5. Competitive Scenario
    • 7.11.3. Saudi Arabia
      • 7.11.3.1. Saudi Arabia Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.11.3.2. Key Country Dynamics
      • 7.11.3.3. Regulatory Framework
      • 7.11.3.4. Reimbursement Scenario
      • 7.11.3.5. Competitive Scenario
    • 7.11.4. Egypt
      • 7.11.4.1. Egypt Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.11.4.2. Key Country Dynamics
      • 7.11.4.3. Regulatory Framework
      • 7.11.4.4. Reimbursement Scenario
      • 7.11.4.5. Competitive Scenario
    • 7.11.5. Oman
      • 7.11.5.1. Oman Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.11.5.2. Key Country Dynamics
      • 7.11.5.3. Regulatory Framework
      • 7.11.5.4. Reimbursement Scenario
      • 7.11.5.5. Competitive Scenario
    • 7.11.6. UAE
      • 7.11.6.1. UAE Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.11.6.2. Key Country Dynamics
      • 7.11.6.3. Regulatory Framework
      • 7.11.6.4. Reimbursement Scenario
      • 7.11.6.5. Competitive Scenario
    • 7.11.7. Kuwait
      • 7.11.7.1. Kuwait Adhesion Barrier Market, 2021 - 2033 (USD Million)
      • 7.11.7.2. Key Country Dynamics
      • 7.11.7.3. Regulatory Framework
      • 7.11.7.4. Reimbursement Scenario
      • 7.11.7.5. Competitive Scenario

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2025
    • 8.3.4. Johnson & Johnson
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Procedure benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Baxter International Inc.,
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Procedure benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Becton Dickinson and Company (BD)
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Procedure benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Integra LifeSciences Holdings Corporation
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Procedure benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Anika Therapeutics
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Procedure benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Atrium Medical Corporation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Procedure benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Fziomed, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Procedure benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Sanofi
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Procedure benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. PlantTec Medical GmbH
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Procedure benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Hangzhou Singclean Medical Products Co.,Ltd
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Procedure benchmarking
      • 8.3.13.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제